Home › Sickle Cell Disease › Indiana
Sickle Cell Disease clinical trials in Indiana
5 studies for Sickle Cell Disease are looking for participants at sites in Indiana.
Cities in Indiana
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- Indiana Hemophilia & Thrombosis Center, Indianapolis
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07656415A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07187973ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Indiana University Health Riley Hospital for Children- Site Number : 8400056, Indianapolis
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Jul 29, 2026 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Riley Children's Hospital (MRD-HCT), Indianapolis
- Riley's Children Hospital (NT-DMT), Indianapolis
RecruitingObservational study
Ages 3 to 20 · All sexes · Updated Jun 4, 2026 · NCT06941389From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.